Urology Billing Services: Why Urology Practices Lose Revenue on Their Highest-Value Procedures

By Medtransic Team | March 8, 2026 | 10 min read | Updated: July 3, 2026

Quick Summary: Urology bills the same anatomy at a dozen different depths — and the code set is built out of families where one comprehensive code swallows its components. Stone procedures, cystoscopy work, BPH devices, urodynamics: each has a specific way of paying wrong. Here are the actual bundling rules, global-period traps, and add-on codes that decide urology revenue.

Urology's billing problem is structural. The specialty's work concentrates in endoscopic and procedural code families where CPT deliberately builds comprehensive codes out of component ones — a ureteroscopy code that already includes the lithotripsy and the stent, a cystoscopy base that lives inside every deeper scope procedure, a device add-on that only pays if someone remembers add-ons exist. Bill the components separately and you get bundling denials or audit exposure. Bill the comprehensive code without knowing what it includes and you either leave add-ons uncaptured or double-bill what's already inside.

This article maps the specific places urology revenue is won and lost — with the codes — so you can hold your own billing operation up against it. It's the same map Medtransic's urology billing team works from.

• One code Uretero-Litho + Stent, One Code - Includes the lithotripsy and the indwelling stent
• 90 days Global Period on Major Procedures - Related post-op care is inside the payment
• Add-on UroLift Add-On Units - Each additional implant beyond the first code
• Screening Medicare PSA Screening - Distinct from diagnostic PSA orders

Stone Billing: Where Unbundling Goes to Get Denied

Kidney stone care is high-volume, high-value, and built around a code family that punishes imprecision. The core distinction: one code covers cystourethroscopy with ureteroscopy and laser lithotripsy; a separate comprehensive code covers the same work plus insertion of an indwelling ureteral stent. When a stent goes in during the stone procedure, the correct claim is the single comprehensive stone-plus-stent code alone — not the ureteroscopy-with-lithotripsy code plus a standalone stent code. That combination is one of the most reliably edited claim patterns in urology: at best a denial and rework, at worst a pattern in your data that a payer's integrity unit eventually notices.

Real stone care is also rarely one procedure. Bilateral stones need the correct laterality (right, left, or bilateral) billing handled correctly, payer-dependent. A staged second procedure — the patient comes back for the other side, or for the fragment that wouldn't pass — needs the planned/staged-procedure modifier, not the unplanned-related-return modifier, which marks an unplanned complication and pays differently. And extracorporeal shockwave lithotripsy sits alongside the ureteroscopic codes as its own path with its own global period. A biller who treats every stone encounter as a lookup rather than a sequence will get individual claims paid and still leak money across the episode.

The Cystoscopy Family: One Base Code, Many Depths

Diagnostic cystourethroscopy is urology's front door — and CPT treats it as the included first step of nearly every deeper endoscopic procedure. Scope plus biopsy, scope plus bladder tumor resection, scope plus stent: each has its own comprehensive code, and the diagnostic scope is inside all of them. The two failure modes are mirror images. Billing the diagnostic scope alongside a deeper procedure on the same session is unbundling. But defaulting everything to a comprehensive code when only a diagnostic scope happened — or coding a tumor resection without capturing what the operative note actually supports about size and technique — underprices real work. The difference between the bladder tumor resection codes is driven by tumor size, and the operative note either documents it or the coder guesses low.

BPH Device Procedures: High Value, High Scrutiny

BPH treatment has shifted heavily toward office- and ASC-based device procedures, and the billing follows the devices. UroLift is billed with a base code for the first implant and an add-on for each additional implant placed — and since typical cases place multiple implants, a billing operation that drops or undercounts those add-on units is walking away from a large share of the procedure's value, case after case. Rezūm water vapor therapy runs through its own procedure code. TURP remains the reference procedure, with a 90-day global and its own well-established rules.

Two things make this category leak. First, prior authorization: most commercial payers gate these procedures behind documented symptom scores, medication trials, and anatomic criteria — an authorization built without the payer's specific checklist is a denial that costs weeks. Second, site-of-service economics: the same procedure bills differently in the office versus the ASC, and device cost sits on the practice in the office setting — so a practice that hasn't modeled where each procedure nets out is making the decision blind. A urology billing partner should be able to show you, per payer, what each pathway actually reimburses.

The Office Engine: Urodynamics, Instillations, Catheters

Between procedures, urology offices run a steady engine of smaller services whose billing is more intricate than their size suggests. Urodynamics is the standout: a complete study is legitimately several codes on the same claim — the complex cystometrogram with voiding pressure study, the abdominal voiding pressure add-on, electromyography, complex uroflowmetry — assembled per what was actually performed and documented. Practices that bill a single urodynamics code per session, because that's what the superbill template had on it, systematically underbill every study.

• Intravesical therapy: bladder instillations bill the instillation administration plus the drug itself as a separate line, each agent carrying its own drug code — BCG and other agents included, and the drug line going missing is a quiet, repeated loss on an oncology-adjacent service.
• Catheter management: routine changes and complicated insertions have distinct codes, and the distinction lives in the documentation.
• Medicare screening: PSA screening for Medicare patients bills under its own dedicated screening code, distinct from a diagnostic PSA order — a screening benefit with its own frequency rules.

Global Periods: The 90-Day Shadow Over Everything

Most major urology procedures carry a 90-day global period, which means the specialty's follow-up-heavy rhythm is constantly interacting with bundling rules. The visit for the post-TURP patient is inside the global. The return to the OR for bleeding is billable — with the unplanned-related-return modifier, at a reduced rate. The planned second-stage stone procedure is billable in full — with the planned/staged-procedure modifier. The completely unrelated new problem during the global window is billable — with the unrelated-procedure modifier, at full payment and a new global. Choosing among these global-period modifiers isn't clerical trivia; each maps to a different clinical story and a different payment, and payers audit for mismatches between the modifier and the operative documentation. The same discipline applies to stent removals after stone procedures: whether that encounter is billable depends on what was billed for the original procedure and how the removal is performed.

What to Ask a Urology Billing Partner

The code families above give you a concrete interview script:

1. When a stone procedure includes a stent, what goes on the claim? (One correct answer: the single comprehensive stone-plus-stent code alone. Anything else, keep looking.)
2. How do you decide between the planned/staged, unplanned-related-return, and unrelated-procedure global-period modifiers for returns during a global period — and who reads the operative note to make that call?
3. On UroLift cases, how do you verify the add-on implant unit count against the operative note?
4. Show me a complete urodynamics claim from a urology client (redacted). How many codes are on it?
5. On instillation encounters, is the drug's own billing line on every claim where an agent was administered?
6. Who runs BPH device prior authorizations in your model, and do you track each payer's criteria checklist?

Urology billing rewards exactly one thing: knowing what's inside each code. That knowledge is checkable — in your own claims data — and building it is what Medtransic's urology billing program exists for, with prior authorization support and denial management around it. Request a billing review and we'll audit your stone, scope, device, and urodynamics claims against every rule in this article.

Sources & References

• CMS — National Correct Coding Initiative — the payer bundling rules governing how procedures done together are billed
• CMS — Medicare Physician Fee Schedule — global periods and payment policy
• AMA CPT — urinary system procedure codes
• American Urological Association — coding and reimbursement resources